Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 93,761 | 8,192 | 0 | 0 | 0 |
| Cost of Goods | 1,590 | 707 | N/A | N/A | N/A |
| Gross Profit | 92,171 | 7,485 | N/A | N/A | N/A |
| Operating Expenses | 63,125 | 122,999 | 66,767 | 59,517 | 51,438 |
| Operating Income | 29,636 | -114,807 | -66,767 | -59,517 | -51,438 |
| Other Income | 6,519 | 111,952 | 4,355 | 5,006 | 5,288 |
| Pre-tax Income | 36,155 | -2,855 | -62,412 | -54,511 | -46,150 |
| Income Tax | -882 | 1,552 | N/A | N/A | N/A |
| Net Income Continuous | 37,037 | -4,407 | -62,412 | -54,511 | -46,150 |
| Net Income | $37,037 | $-4,407 | $-62,412 | $-54,511 | $-46,150 |
| EPS Basic Total Ops | 0.38 | -0.05 | -0.72 | -0.63 | -0.54 |
| EPS Basic Continuous Ops | 0.38 | -0.05 | -0.72 | -0.63 | -0.54 |
| EPS Diluted Total Ops | 0.38 | -0.05 | -0.72 | -0.63 | -0.54 |
| EPS Diluted Continuous Ops | 0.38 | -0.05 | -0.72 | -0.63 | -0.54 |
| EPS Diluted Before Non-Recurring Items | 0.38 | -0.05 | -0.72 | N/A | N/A |
| EBITDA(a) | $30,382 | $-114,399 | $-66,651 | $-59,414 | $-51,339 |